Mikronika - Company finances
|
EUR
|
2023
From: 2023-03-06
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|
|
Financial data
|
|||
| Sales revenue | 274 | 3,724 | 21,698 |
| Profit before tax | -387 | -585 | 4,337 |
| Net profit | -387 | -585 | 4,135 |
| Equity | -386 | -971 | 3,164 |
| Liabilities | 3,401 | 7,748 | 4,976 |
| Non-current assets | 0 | 0 | 0 |
| Current assets | 3,015 | 6,777 | 7,961 |
| Total assets | 3,015 | 6,777 | 7,961 |
|
Taxes paid
|
|||
| STI taxes | - | 17 | 2,598 |
|
Financial indicators
|
|||
| Revenue change y/y | - | +1259.1% | +482.7% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -12.8% | -8.6% | 51.9% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | 130.7% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -141.2% | -15.7% | 19.1% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -141.2% | -15.7% | 20.0% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | 1.6 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Mikronika - Social security debts
The company had no debts to Sodra
Mikronika - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-03-27 | 2026-04-01 | 8.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Mikronika, MB (code 306265492) is a Small partnership engaged in retail sale of pharmaceutical products. In the latest financial year, 2025, the company generated revenue of EUR 21.7K and net profit of EUR 4.1K, with a profit margin of 19.1%. This followed a clear turnaround from 2024, when revenue was EUR 3.7K and the company posted a net loss of EUR 585. Revenue also increased from EUR 274 in 2023, showing strong growth over the three-year period. For 2025, revenue growth reached 482.6% year on year and 7,819.0% over two years, reflecting a much larger sales base than in the earlier periods. The balance sheet remained modest, with total assets of EUR 8.0K, equity of EUR 3.2K and liabilities of EUR 5.0K at the end of 2025. Key efficiency indicators were strong, with asset turnover at 2.73x, while returns on equity and assets were elevated, supported by the small equity and asset base.